September 27, 2024- BD announced new data that highlights how its advanced artificial intelligence technology can help health systems better identify incidents of controlled substance diversion in the operating room.
Hospital drug diversion occurs when a health care worker “diverts” opioids or other controlled substances away from patients for personal use or sale. The operating room is one of the highest risk areas for the diversion of controlled substances, such as narcotics used for anesthesia and pain management.
A new research study conducted at an Ochsner Health medical center and published in the American Journal of Health-System Pharmacy (AJHP) shows how the use of artificial intelligence in BD HealthSightTM Diversion Management software can help highlight blind spots about the movement of medication in the operating room that are undetected by current manual processes.
The system uses artificial intelligence and advanced analytics to provide a deep level of connectivity and visibility into the behaviors of individuals interacting with medication storage, management and pharmacy systems, which is a critical need for large, complex health systems with hundreds of points of controlled substance dispensing across multiple sites.